Low maternal serum matrix metalloproteinase (MMP)-2 concentrations are associated with preterm labor and fetal inflammatory response

Journal of Perinatal Medicine

Volumn 38, Issue 6, 2010, Pages 589-596

  Koucký, Michal ^a   Germanová, Anna ^a,b   Kalousová, Marta ^b   Hill, Martin ^c   Cindrová Davies, Tereza ^d   Pařízek, Antonín ^a   Švarcová, Jana ^b   Zima, Tomáš ^b   Hájek, Zdeněk ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

IL 10; IL 6; Matrix metalloproteinases; Preterm labor; Soluble receptor for advanced glycation end products (sRAGE)

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; C REACTIVE PROTEIN; GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 6; NEUTROPHIL COLLAGENASE;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FUNISITIS; GESTATIONAL AGE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MATERNAL SERUM; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; UMBILICAL CORD; UMBILICAL CORD BLOOD;

C-REACTIVE PROTEIN; CHORIOAMNIONITIS; FEMALE; FETAL BLOOD; FETUS; HUMANS; INFANT, NEWBORN; INTERLEUKIN-10; MATRIX METALLOPROTEINASES; MULTIVARIATE ANALYSIS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RECEPTORS, IMMUNOLOGIC; REGRESSION ANALYSIS;

EID: 78650139090     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2010.092     Document Type: Article

References (34)

1. Buhimschi CS, Baumbusch MA, Dulay AT, Oliver EA, Lee S, Zhao G, et al. Characterization of RAGE, HMGB1, and S100b in inflammation-induced preterm birth and fetal tissue injury. Am J Pathol. 2009;175:958-75.
2. Buhimschi CS, Buhimschi IA, Abdel-razeq SS, Rosenberg VA, Thung SF, Zhao G, et al. Proteomic analysis of the amniotic fluid (AF) predicts funisitis and early-onset neonatal sepsis. Am J Obstet Gynecol. 2006;195(Suppl. 1): S170.
3. Buhimschi IA, Zhao G, Pettker CM. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. Am J Obstet Gynecol. 2007;196:181.e1-13.
4. Christiaens I, Zaragoza DB, Guilbert L, Robertson SA, Mitchel BF, Olson DM. Inflammatory process in preterm and term parturition. J Reprod Immunol. 2008;79:50-7.
5. Fortunato SJ, Menon R, Lombardi SJ, LaFleur B. Interleukin-10 inhibition of gelatinases in fetal membranes: therapeutic implications in preterm premature rupture of membranes. Obstet Gynecol. 2001;98:284-8. (Pubitemid 32744763)
6. Germanová A, Koucký M, Hájek Z, Paří zek A, Zima T, Kalousová M. Soluble receptor for advanced glycation end products in physiological and pathological pregnancy. Clin Biochem. 2009; accepted in print Nov. 10.
7. Goldman S, Weiss A, Shalev E. The effect of progesterone on gelatinase expression in the decidua and fetal membranes before and after contractions. Am J Obstet Gynecol. 2007;197:521.e1-7.
8. Gomez R, Romero R, Ghezzi F. The fetal inflammatory response syndrome (FIRS). Am J Obstet Gynecol. 1998;179:194-202. (Pubitemid 28394495)
9. Gotsch F, Romero R, Kusanovic JP. The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection/inflammation, and spontaneous parturition at term: a role for interleukin-10. J Matern Fetal Neonanatal Med. 2008;21:529-47.
10. Grammatopoulos DK. The role of CRH receptors and their agonists in myometrial contractility and quiescence during pregnancy and labor. Front Biosci. 2007;12:561-71. (Pubitemid 46852806)
11. Hájek Z, Germanová A, Koucký M, Zima T, Kopecký P, Vítková I, et al. Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study. J Perinat Med. 2008;36:399-404.
12. Hanna N, Bonifacio L, Weinberger B, Reddy P, Murphy S, Romero R. Evidence of interleukin-10-mediated inhibition of cyclo-oxygenase expression and prostaglandin production in preterm human placenta. Am J Reprod Immunol. 2006;55:19-27. (Pubitemid 43328932)
13. Hanna N, Hanna I, Hleb M, Wagner E, Dougherty J, Balkundi D. Gestational age-dependent expression of IL-10 and its receptor in human placental tissues and isolated cytotrophoblasts. J Immunol. 2000;164:5721-8. (Pubitemid 30389814)
14. Hudson BI, Harja E, Moser B, Schmidt AM. Soluble receptor for advanced glycation end products (sRAGE) and coronary artery disease. The next C-reactive protein? Arterioscler Thromb Vasc Biol. 2005;25:879-82. (Pubitemid 40637200)
15. Kalousová M, Hodková M, Kazderová M, Fialova J, Tesar V, Dusilova-Sulkova S, et al. Soluble receptor for advanced glycation end products in patients with decreased renal function. Am J Kidney Dis. 2006;47:406-11. (Pubitemid 43255173)
16. Kim KW, Romero R, Park HS. A rapid matrix metalloproteinase-8 bedside test for the detection of intraamniotic inflammation in women with preterm premature of membranes. Am J Obstet Gynecol. 2007;197:292.e1-5.
17. Lee SE, Romero R, Park IS, Seong HS, Park CW, Yoon BH. Amniotic fluid prostaglandin concentrations increase before the onset of spontaneous labor at term. J Matern Fetal Neonatal Med. 2008;21:89-94. (Pubitemid 351196239)
18. Lemanczevicz A, Laudanski P, Kuc P, Pierzynski P, Kretowska M, Urban J. Matrix metalloproteinase-2 urine levels in preterm laboring patients. Arch Perinat Med. 2007;13:50-52.
19. Makrakis E, Grigoriou O, Kouskouni E. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in plasma/serum and urine of women during term and threatened preterm labor: a clinical approach. J Matern Fetal Neonatal Med. 2003;14:170-6. (Pubitemid 37186639)
20. Maymon E, Romero R, Pacora P, Gervasi MT, Gomez R, Edwin SS, et al. Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes and intraamniotic infection. Am J Obstet Gynecol. 2000;83:887-94.
21. Mendelson CR. Minireview: fetal-maternal hormonal signaling in pregnancy and labor. Mol Endocrinol. 2009;23:947-54.
22. Park CW, Lee SM, Park JS, Jun. JK. The antenatal identification of funisitis with rapid MMP-8 bedside test. J Perinat Med. 2008;36:497-502.
23. Park L, Roman KG, Kee KJ. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med. 1998;4:1025-31. (Pubitemid 28417334)
24. Pullerits R, Bokarewa M, Dahlberg R, Tarkowski A. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther. 2005;7:817-24.
25. Rawlings ND, Barret AJ. Evolutionary families of metallopeptidases. Meth Enzymol. 1995;248:183-228.
26. Romero R, Espinoza J, Goncalves LF. The role of inflammation and infection in preterm birth. Semin Reprod Med. 2007;25:21-39. (Pubitemid 46147842)
27. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Nien NK. Inflammation in preterm and term labor and delivery. Semin Fetal Neonatal Med. 2006;11:317-26. (Pubitemid 44038705)
28. Romero R, Espinoza J, Hassan S. Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation. J Perinat Med. 2008;36:388-98.
29. Romero R, Epinoza J, Kusanovic JP. The preterm parturition syndrome. BJOG. 2006;113:17-42. (Pubitemid 44934664)
30. Schmidt AM, Yanc SD, Yana SF, Stern DM. The biology of the receptor for advanced glycation end products and its ligand. BBA - Mol Cell Res. 2000;1498:99-111.
31. Schwartz N, Xue X, Elovitz MA, Dowling O, Metz CN. Progesterone suppresses the fetal inflammatory response ex vivo. Am J Obstet Gynecol. 2009;201:211.e1-9.
32. Wear-Maggitti K, Lee J, Conejero A, Schmidt AM, Grant R, Breitbart A. Use of topical sRAGE in diabetic wounds increases neovascularization and granulation tissue formation. Ann Plast Surg. 2004;52:519-21.
33. Weiss A, Goldman S, Shalev E. The matrix metalloproteinases (MMPs) in the decidua and fetal membranes. Front Biosci. 2007;12:649-59. (Pubitemid 46860207)
34. Zhang H, Tasaka S, Shiraishi Y. Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury. Am J Respir Care Med. 2008;178:256-62.